PATENT CLAIM ANALYSIS

Application Number: 16027029
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-02
Patent Classification: ["548", "400000"]

Abstract:
Provided herein are Mcl-1 antagonist compositions and methods of treating cancer using the compositions described herein.

Claim (Index 100):
The method of  claim 99 , wherein:\n L 5  is a bond, \u2014O\u2014, substituted or unsubstituted C 1 -C 5  alkylene or substituted or unsubstituted 1-5 membered heteroalkylene; and R 5  is R 13 -substituted C 1 -C 3  alkyl or unsubstituted C 1 -C 5  alkyl, wherein R 13  is substituted or unsubstituted 6 membered heterocycloalkyl or substituted or unsubstituted 6 membered heteroaryl.

Metadata:
- Claim Count in Document: 245.0
- Percentile: 95.0
- Lexical Diversity: 1.13333
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15123232', '15662861', '15700040', '15214282', '15421258']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.820874696262985
- 35 USC 102 Novelty (BERT): 0.6553867321460743
- Combined Prediction Score: 0.8043258998512939
- Mean Citation Score: 615.5831919999998
- Max Citation Score: 733.3489
- Similarity Product: 580.113517884922

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test